Apart from Victoza, which was approved for Type 2 diabetes in 2010, liraglutide also underpins Novo’s older weight loss drug Saxenda and its insulin-degludec-based diabetes combination therapy ...
A recent study published in the journal Diabetes Care found that the combination of Technosphere insulin (TI) plus insulin degludec is non-inferior to the usual care of an automated insulin delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback